Wall Street Zen Upgrades Varex Imaging (NASDAQ:VREX) to “Strong-Buy”

Varex Imaging (NASDAQ:VREX) was upgraded by research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

Several other brokerages have also commented on VREX. Jefferies Financial Group reaffirmed a “hold” rating and issued a $14.50 price objective on shares of Varex Imaging in a research report on Monday, February 2nd. Oppenheimer dropped their target price on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. B. Riley Financial reaffirmed a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a research note on Monday, December 29th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $16.17.

Varex Imaging Stock Down 2.6%

Varex Imaging stock opened at $13.17 on Friday. Varex Imaging has a 1-year low of $6.76 and a 1-year high of $14.56. The business has a fifty day moving average price of $13.30 and a 200-day moving average price of $12.23. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.89 and a quick ratio of 1.87. The stock has a market capitalization of $551.82 million, a price-to-earnings ratio of -8.03 and a beta of 0.88.

Varex Imaging (NASDAQ:VREX) last announced its earnings results on Tuesday, February 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.05. The company had revenue of $209.60 million for the quarter, compared to analyst estimates of $207.83 million. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. Equities research analysts forecast that Varex Imaging will post 0.53 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in VREX. Empowered Funds LLC lifted its position in Varex Imaging by 7.3% during the first quarter. Empowered Funds LLC now owns 179,128 shares of the company’s stock valued at $2,078,000 after purchasing an additional 12,151 shares during the period. Jane Street Group LLC raised its stake in shares of Varex Imaging by 17.9% during the 1st quarter. Jane Street Group LLC now owns 159,362 shares of the company’s stock valued at $1,849,000 after buying an additional 24,160 shares during the last quarter. Cooke & Bieler LP lifted its holdings in shares of Varex Imaging by 0.7% in the 2nd quarter. Cooke & Bieler LP now owns 2,136,843 shares of the company’s stock valued at $18,526,000 after buying an additional 14,160 shares during the period. Savant Capital LLC acquired a new position in shares of Varex Imaging in the 2nd quarter valued at about $154,000. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of Varex Imaging by 228.7% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 102,380 shares of the company’s stock worth $888,000 after buying an additional 71,237 shares during the last quarter.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.